NMI
N-myc-interactor
Also known as: NMI_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13287
- Gene
- NMI
- Ensembl
- ENSG00000123609
- Chromosome
- 2
- Canonical length
- 307 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Secretome location
- Secreted to blood
OverviewNCBI Gene
NMYC interactor (NMI) encodes a protein that interacts with NMYC and CMYC (two members of the oncogene Myc family), and other transcription factors containing a Zip, HLH, or HLH-Zip motif. The NMI protein also interacts with all STATs except STAT2 and augments STAT-mediated transcription in response to cytokines IL2 and IFN-gamma. The NMI mRNA has low expression levels in all human fetal and adult tissues tested except brain and has high expression in cancer cell line-myeloid leukemias. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
307 residues, UniProt reviewed canonical sequence.
>Q13287|NMI
1 MEADKDDTQQ ILKEHSPDEF IKDEQNKGLI DEITKKNIQL KKEIQKLETE LQEATKEFQI
61 KEDIPETKMK FLSVETPEND SQLSNISCSF QVSSKVPYEI QKGQALITFE KEEVAQNVVS
121 MSKHHVQIKD VNLEVTAKPV PLNSGVRFQV YVEVSKMKIN VTEIPDTLRE DQMRDKLELS
181 FSKSRNGGGE VDRVDYDRQS GSAVITFVEI GVADKILKKK EYPLYINQTC HRVTVSPYTE
241 IHLKKYQIFS GTSKRTVLLT GMEGIQMDEE IVEDLINIHF QRAKNGGGEV DVVKCSLGQP
301 HIAYFEELocalizationUniProt · AlphaFold · HPA
Whether an antibody against NMI can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 70 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 70 nTPM
- spleen: 45 nTPM
- appendix: 42 nTPM
- thymus: 41 nTPM
- lymph node: 41 nTPM
- liver: 33 nTPM
Single-cell type
- neutrophils: 260 nCPM
- megakaryocytes: 161 nCPM
- migrating cytotrophoblasts: 122 nCPM
- neutrophil progenitors: 113 nCPM
- megakaryocyte progenitors: 106 nCPM
- megakaryocyte-erythroid progenitors: 97 nCPM
Immune cell
- neutrophil: 469 nTPM
- basophil: 253 nTPM
- intermediate monocyte: 173 nTPM
- non-classical monocyte: 171 nTPM
- eosinophil: 141 nTPM
- classical monocyte: 122 nTPM
Brain region
- medulla oblongata: 7.7 nTPM
- spinal cord: 6.5 nTPM
- white matter: 6.4 nTPM
- thalamus: 5.9 nTPM
- midbrain: 5.7 nTPM
- hypothalamus: 5.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.12
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.13
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor signaling pathway via JAK-STAT
- innate immune response
- macrophage activation involved in immune response
- negative regulation of cell population proliferation
- negative regulation of innate immune response
- negative regulation of interferon-alpha production
- negative regulation of interferon-beta production
- negative regulation of non-canonical NF-kappaB signal transduction
- positive regulation of inflammatory response
- positive regulation of innate immune response
- positive regulation of non-canonical NF-kappaB signal transduction
- positive regulation of protein K48-linked ubiquitination
- protein K48-linked ubiquitination
- response to virus
- toll-like receptor 4 signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NMI in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NMI as an antibody target. Whether an autoantibody or antibody against NMI could matter depends on whether native NMI is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NMI is annotated as secreted, so native NMI circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label NMI as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...